Markets › India › NSE › MEDICAMEQ

Medicamen Biotech Ltd

NSE:MEDICAMEQHealthcare

₹272.00−4.38%At closeAt close · Mon 19 Oct · ≈ AED 10.49 · Market cap $40.46M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	29.7%	41.6%	48.8%	47.5%	24.0%	27.3%	—	—
Operating margin	15.5%	16.2%	13.0%	28.8%	4.2%	6.3%	6.3%	+0.0 pts
Net margin	10.8%	12.9%	10.5%	6.1%	4.4%	4.9%	4.9%	+0.0 pts
EBITDA margin	18.1%	22.4%	19.7%	13.7%	12.4%	11.5%	—	—
Return on equity	9.1%	10.2%	7.7%	5.3%	3.3%	3.5%	3.5%	+0.0 pts
Return on assets	6.3%	6.6%	5.3%	3.7%	2.4%	2.6%	2.6%	+0.0 pts
Return on capital employed	12.4%	12.2%	9.3%	24.6%	3.1%	4.4%	—	—
Debt / equity	0.1×	0.2×	0.1×	0.2×	0.2×	0.2×	0.2×	+0.0%
Debt / assets	9.7%	11.4%	9.2%	10.6%	11.2%	12.8%	—	—
Interest coverage	11.6×	9.6×	5.4×	11.8×	2.2×	3.5×	—	—
Current ratio	1.8×	1.7×	2.0×	1.9×	2.1×	2.5×	2.5×	+0.0%
Quick ratio	1.7×	1.3×	1.4×	1.2×	1.3×	1.7×	—	—
Cash ratio	0.1×	0.1×	0.3×	0.2×	0.0×	0.4×	0.4×	+0.0%
Asset turnover	0.6×	0.5×	0.5×	0.6×	0.5×	0.5×	—	—
Inventory turnover	15.2×	2.5×	1.6×	1.6×	2.0×	2.1×	—	—
Receivables turnover	2.1×	1.8×	2.2×	3.2×	2.4×	2.4×	—	—
Dividend payout	5.0%	8.2%	8.5%	11.6%	17.9%	14.1%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.